Literature DB >> 28777485

PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.

Anders J Kämpe1, Alice Costantini1, Yael Levy-Shraga2,3, Leonid Zeitlin4, Paul Roschger5, Fulya Taylan1, Anna Lindstrand1,6, Eleftherios P Paschalis5, Sonja Gamsjaeger5, Annick Raas-Rothschild7, Matthias Hövel8, Hong Jiao9, Klaus Klaushofer5, Corinna Grasemann10, Outi Mäkitie1,6,11,12.   

Abstract

Mutations in the PLS3 gene, encoding Plastin 3, were described in 2013 as a cause for X-linked primary bone fragility in children. The specific role of PLS3 in bone metabolism remains inadequately understood. Here we describe for the first time PLS3 deletions as the underlying cause for childhood-onset primary osteoporosis in 3 boys from 2 families. We carried out thorough clinical, radiological, and bone tissue analyses to explore the consequences of these deletions and to further elucidate the role of PLS3 in bone homeostasis. In family 1, the 2 affected brothers had a deletion of exons 4-16 (NM_005032) in PLS3, inherited from their healthy mother. In family 2, the index patient had a deletion involving the entire PLS3 gene (exons 1-16), inherited from his mother who had osteoporosis. The 3 patients presented in early childhood with severe spinal compression fractures involving all vertebral bodies. The 2 brothers in family 1 also displayed subtle dysmorphic facial features and both had developed a myopathic gait. Extensive analyses of a transiliac bone biopsy from 1 patient showed a prominent increase in osteoid volume, osteoid thickness, and in mineralizing lag time. Results from quantitative backscattered electron imaging and Raman microspectroscopy showed a significant hypomineralization of the bone. Together our results indicate that PLS3 deletions lead to severe childhood-onset osteoporosis resulting from defective bone matrix mineralization, suggesting a specific role for PLS3 in the mineralization process.
© 2017 American Society for Bone and Mineral Research. © 2017 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE HISTOMORPHOMETRY; DXA; GENETIC RESEARCH; MATRIX MINERALIZATION; OSTEOPOROSIS

Mesh:

Substances:

Year:  2017        PMID: 28777485     DOI: 10.1002/jbmr.3233

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  14 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

2.  A novel frameshift deletion in PLS3 causing severe primary osteoporosis.

Authors:  Alice Costantini; Panagiotis Ν Krallis; Anders Kämpe; Emmanouil M Karavitakis; Fulya Taylan; Outi Mäkitie; Artemis Doulgeraki
Journal:  J Hum Genet       Date:  2018-06-08       Impact factor: 3.172

3.  Osteogenesis imperfecta mutations in plastin 3 lead to impaired calcium regulation of actin bundling.

Authors:  Christopher L Schwebach; Elena Kudryashova; Weili Zheng; Matthew Orchard; Harper Smith; Lucas A Runyan; Edward H Egelman; Dmitri S Kudryashov
Journal:  Bone Res       Date:  2020-05-22       Impact factor: 13.567

Review 4.  Plastin 3 in health and disease: a matter of balance.

Authors:  Lisa Wolff; Eike A Strathmann; Ilka Müller; Daniela Mählich; Charlotte Veltman; Anja Niehoff; Brunhilde Wirth
Journal:  Cell Mol Life Sci       Date:  2021-05-23       Impact factor: 9.261

5.  A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders.

Authors:  Sanne Treurniet; Elisabeth M W Eekhoff; Felix N Schmidt; Dimitra Micha; Björn Busse; Nathalie Bravenboer
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-23       Impact factor: 5.555

Review 6.  New Insights Into Monogenic Causes of Osteoporosis.

Authors:  Riikka E Mäkitie; Alice Costantini; Anders Kämpe; Jessica J Alm; Outi Mäkitie
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-25       Impact factor: 5.555

7.  Osteogenesis imperfecta mutations in plastin 3 lead to impaired calcium regulation of actin bundling.

Authors:  Christopher L Schwebach; Elena Kudryashova; Weili Zheng; Matthew Orchard; Harper Smith; Lucas A Runyan; Edward H Egelman; Dmitri S Kudryashov
Journal:  Bone Res       Date:  2020-05-22       Impact factor: 13.567

8.  A novel mutation in PLS3 causes extremely rare X-linked osteogenesis imperfecta.

Authors:  Jing Hu; Lu-Jiao Li; Wen-Bin Zheng; Di-Chen Zhao; Ou Wang; Yan Jiang; Xiao-Ping Xing; Mei Li; Weibo Xia
Journal:  Mol Genet Genomic Med       Date:  2020-11-09       Impact factor: 2.183

9.  PLS3 Mutations Cause Severe Age and Sex-Related Spinal Pathology.

Authors:  Riikka E Mäkitie; Tuukka Niinimäki; Maria Suo-Palosaari; Anders Kämpe; Alice Costantini; Sanna Toiviainen-Salo; Jaakko Niinimäki; Outi Mäkitie
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-23       Impact factor: 5.555

10.  Rare Copy Number Variants in Array-Based Comparative Genomic Hybridization in Early-Onset Skeletal Fragility.

Authors:  Alice Costantini; Sini Skarp; Anders Kämpe; Riikka E Mäkitie; Maria Pettersson; Minna Männikkö; Hong Jiao; Fulya Taylan; Anna Lindstrand; Outi Mäkitie
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.